FDA Inspection
Fenwal International, Inc.Fenwal International, Inc. – FDA Inspection, Aug 22, 2017
Record Details
This FDA Inspection record concerns Fenwal International, Inc., with an inspection on August 22, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 75dd0303-af0a-4c83-b6f1-f18930602a2a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1022483
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 314.81(b)(1)(ii)Failure to meet specifications
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fenwal International, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | San Juan District Office | Blood and Blood Products |
| September 18, 2024 | VAI | San Juan District Office | Blood and Blood Products |
| September 24, 2022 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 24, 2021 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 26, 2019 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Fenwal International, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.